| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Daunderer M |
Akute Intoxikationen (25): Rausch- und Suchtmittel VII |
Beilage zur Med. Kli... |
1973 |
| Andrew Weil |
Letters From Andrew Weil: The Love Drug |
Journal of Psychedel... |
1976 |
| Davis WM, Borne RF |
Pharmacologic investigation of compounds related to 3,4-methylenedioxy... |
Subst Alcohol Action... |
1984 |
| Noggle FT Jr, DeRuiter J,... |
Spectrophotometric and liquid chromatographic identification of 3,4-me... |
J Assoc Off Anal Che... |
1986 |
| Nichols DE, Hoffman AJ, O... |
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives ... |
J Med Chem |
1986 |
| Noggle FT Jr, DeRuiter J,... |
Synthesis, identification, and acute toxicity of some N-alkyl derivati... |
J Assoc Off Anal Che... |
1987 |
| Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
| Stanford MW |
Designer drugs: Medical aspects and clinical management |
Alcoholism Treatment... |
1988 |
| Fitzgerald RL, Blanke RV,... |
Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxym... |
J Chromatogr |
1989 |
| Schmidt CJ, Kehne JH |
Neurotoxicity of MDMA: neurochemical effects |
Ann N Y Acad Sci |
1990 |
| Yousif MY, Fitzgerald RL,... |
Identification of metabolites of 3,4-methylenedioxymethamphetamine in ... |
Drug Alcohol Depend |
1990 |
| Lim HK, Foltz RL |
In vivo formation of aromatic hydroxylated metabolites of 3,4-(methyle... |
Biol Mass Spectrom |
1991 |
| Miller RT, Serrine SL, Mo... |
Metabolism of 5-(Glutathion-S-yl)-a-methyldopamine Following Intracere... |
Chem Res Toxicol |
1995 |
| Miller RT, Lau SS, Monks ... |
Effects of intracerebroventricular administration of 5-(glutathion-S-y... |
Chem Res Toxicol |
1996 |
| Parker MA, Marona-Lewicka... |
Synthesis and pharmacological evaluation of ring-methylated derivative... |
J Med Chem |
1998 |
| Schwab M, Seyringer E, Br... |
Fatal MDMA intoxication |
Lancet |
1999 |
| de la Torre R, Farré M, O... |
Non-linear pharmacokinetics of MDMA (`ecstasy') in humans |
Br J Clin Pharmacol |
2000 |
| de la Torre R, Farre M, O... |
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans |
Br J Clin Pharmacol |
2000 |
| Christophersen AS |
Amphetamine designer drugs - an overview and epidemiology |
Toxicol Lett |
2000 |
| Borth S, Hänsel W, Rösner... |
Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their re... |
Forensic Sci Int |
2000 |
| Kavanagh P, Dunne J, Feel... |
Phenylalkylamine abuse among opiate addicts attending a methadone trea... |
Addict Biol |
2001 |
| Carter JF, Titterton EL, ... |
Isotopic characterisation of 3,4-methylenedioxyamphetamine and 3,4-met... |
Analyst |
2002 |
| Zalish M, Lavie V |
Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and s... |
Vision Res |
2003 |
| Lebsanft HB, Mayerhofer A... |
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unila... |
J Neural Transm |
2003 |
| Buechler J, Schwab M, Mik... |
Enantioselective quantitation of the ecstasy compound R- and S-N-ethyl... |
J Chromatogr B Analy... |
2003 |
| Dumasia MC |
Identification of some N-hydroxylated metabolites of +/--3,4-methylene... |
Xenobiotica |
2003 |
| Darlington CL |
Dexanabinol: A novel cannabinoid with neuroprotective properties |
IDrugs |
2003 |
| Easton N, Fry J, O'Shea E... |
Synthesis, in vitro formation, and behavioural effects of glutathione ... |
Brain Res |
2003 |
| Moyano S, Frechilla D, De... |
NMDA receptor subunit and CaMKII changes in rat hippocampus induced by... |
Psychopharmacology (... |
2004 |
| Segura M, Farre M, Pichin... |
Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetami... |
Clin Pharmacokinet |
2005 |
| Capela JP, Macedo C, Bran... |
Neurotoxicity mechanisms of thioether ecstasy metabolites |
Neuroscience |
2007 |
| Benzenhöfer U, Passie T |
Rediscovering MDMA ecstasy: the role of the American chemist Alexander... |
Addiction |
2010 |
| Karila L, Reynaud M |
GHB and synthetic cathinones: clinical effects and potential consequen... |
Drug Test Anal |
2010 |
| Casale JF, Hays PA |
Characterization of the “Methylenedioxy-2-aminoindans” |
Microgram Journal |
2011 |
| Sainsbury PD, Kicman AT, ... |
Aminoindanes-the next wave of 'legal highs'? |
Drug Test Anal |
2011 |
| Gallagher CT, Assi S, Sta... |
5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to 'legal ... |
Hum Psychopharmacol |
2012 |
| Dal Cason TA, Corbett CA,... |
An unusual clandestine laboratory synthesis of 3,4-methylenedioxyamphe... |
Forensic Sci Int |
2012 |
| Uchiyama N, Matsuda S, Ka... |
Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indaz... |
Forensic Sci Int |
2014 |
| Wolfson PE |
An Interview with Richard Yensen : Psychedelic Experiential Pharmacolo... |
International Journa... |
2014 |
| Van Hout MC, Hearne E |
Word of mouse: indigenous harm reduction and online consumerism of the... |
J Psychoactive Drugs |
2015 |
| McLaughlin G, Morris N, K... |
Test purchase, synthesis, and characterization of 2-methoxydiphenidine... |
Drug Test Anal |
2015 |
| Passie T, Benzenhöfer U |
The History of MDMA as an Underground Drug in the United States, 1960-... |
J Psychoactive Drugs |
2016 |
| Kang H, Park P, Bortolott... |
Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor ... |
Neuropharmacology |
2017 |
| Pinterova N, Horsley RR, ... |
Synthetic Aminoindanes: A Summary of Existing Knowledge |
Front Psychiatry |
2017 |
| Passie T |
The early use of MDMA ('Ecstasy') in psychotherapy (1977-1985) |
Drug Science, Policy... |
2018 |
| Bertron JL, Seto M, Linds... |
DARK Classics in Chemical Neuroscience: Phencyclidine (PCP) |
ACS Chem Neurosci |
2018 |
